U.S. markets open in 9 hours 19 minutes
  • S&P Futures

    4,109.75
    -13.25 (-0.32%)
     
  • Dow Futures

    33,894.00
    -102.00 (-0.30%)
     
  • Nasdaq Futures

    13,164.75
    -47.25 (-0.36%)
     
  • Russell 2000 Futures

    2,201.30
    -6.60 (-0.30%)
     
  • Crude Oil

    64.75
    -0.74 (-1.13%)
     
  • Gold

    1,869.70
    +1.70 (+0.09%)
     
  • Silver

    28.15
    -0.19 (-0.66%)
     
  • EUR/USD

    1.2237
    +0.0010 (+0.09%)
     
  • 10-Yr Bond

    1.6420
    +0.0020 (+0.12%)
     
  • Vix

    21.34
    +1.62 (+8.22%)
     
  • GBP/USD

    1.4191
    +0.0004 (+0.03%)
     
  • USD/JPY

    108.9180
    +0.0280 (+0.03%)
     
  • BTC-USD

    40,546.26
    -4,682.02 (-10.35%)
     
  • CMC Crypto 200

    1,117.24
    -135.90 (-10.84%)
     
  • FTSE 100

    7,034.24
    +1.39 (+0.02%)
     
  • Nikkei 225

    28,006.55
    -400.29 (-1.41%)
     

Could These 3 Stocks Be 10-Baggers in 2021?

Adria Cimino, The Motley Fool
·4 min read
Could These 3 Stocks Be 10-Baggers in 2021?
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Ocugen (NASDAQ: OCGN) recently entered the coronavirus vaccine race through a collaboration deal with Bharat Biotech of India. As part of the agreement, Ocugen gains rights to co-develop and commercialize Bharat's vaccine candidate in the United States. A recent report from Bharat's phase 3 trial in India showed the candidate -- Covaxin -- was 81% effective.